SG11202113345WA - Cgrp antagonist compounds - Google Patents
Cgrp antagonist compoundsInfo
- Publication number
- SG11202113345WA SG11202113345WA SG11202113345WA SG11202113345WA SG11202113345WA SG 11202113345W A SG11202113345W A SG 11202113345WA SG 11202113345W A SG11202113345W A SG 11202113345WA SG 11202113345W A SG11202113345W A SG 11202113345WA SG 11202113345W A SG11202113345W A SG 11202113345WA
- Authority
- SG
- Singapore
- Prior art keywords
- antagonist compounds
- cgrp antagonist
- cgrp
- compounds
- antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1908430.0A GB201908430D0 (en) | 2019-06-12 | 2019-06-12 | Cgrp antagonist compounds |
| PCT/GB2020/051429 WO2020249970A1 (en) | 2019-06-12 | 2020-06-12 | Cgrp antagonist compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202113345WA true SG11202113345WA (en) | 2021-12-30 |
Family
ID=67386293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202113345WA SG11202113345WA (en) | 2019-06-12 | 2020-06-12 | Cgrp antagonist compounds |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220251110A1 (en) |
| EP (1) | EP3983417A1 (en) |
| JP (1) | JP2022535994A (en) |
| KR (1) | KR20220020907A (en) |
| CN (1) | CN114245797A (en) |
| AU (1) | AU2020291160A1 (en) |
| BR (1) | BR112021025103A2 (en) |
| CA (1) | CA3143124A1 (en) |
| GB (1) | GB201908430D0 (en) |
| IL (1) | IL288875A (en) |
| SG (1) | SG11202113345WA (en) |
| WO (1) | WO2020249970A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2438067B1 (en) * | 2009-06-05 | 2015-08-26 | Boehringer Ingelheim International GmbH | Spirolactams as cgrp-antagonists |
| CA2816974A1 (en) * | 2010-11-12 | 2012-05-18 | Merck Sharp & Dohme Corp. | Piperidinone carboxamide indane cgrp receptor antagonists |
| TWI501968B (en) * | 2010-11-12 | 2015-10-01 | Merck Sharp & Dohme | Piperidinone carboxamide azaindane cgrp receptor antagonists |
-
2019
- 2019-06-12 GB GBGB1908430.0A patent/GB201908430D0/en not_active Ceased
-
2020
- 2020-06-12 AU AU2020291160A patent/AU2020291160A1/en active Pending
- 2020-06-12 KR KR1020227001005A patent/KR20220020907A/en unknown
- 2020-06-12 JP JP2021573853A patent/JP2022535994A/en active Pending
- 2020-06-12 WO PCT/GB2020/051429 patent/WO2020249970A1/en unknown
- 2020-06-12 SG SG11202113345WA patent/SG11202113345WA/en unknown
- 2020-06-12 CA CA3143124A patent/CA3143124A1/en active Pending
- 2020-06-12 CN CN202080057238.1A patent/CN114245797A/en active Pending
- 2020-06-12 EP EP20734277.5A patent/EP3983417A1/en active Pending
- 2020-06-12 US US17/617,851 patent/US20220251110A1/en active Pending
- 2020-06-12 BR BR112021025103A patent/BR112021025103A2/en unknown
-
2021
- 2021-12-09 IL IL288875A patent/IL288875A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220251110A1 (en) | 2022-08-11 |
| IL288875A (en) | 2022-02-01 |
| EP3983417A1 (en) | 2022-04-20 |
| CA3143124A1 (en) | 2020-12-17 |
| BR112021025103A2 (en) | 2022-02-15 |
| JP2022535994A (en) | 2022-08-10 |
| WO2020249970A1 (en) | 2020-12-17 |
| KR20220020907A (en) | 2022-02-21 |
| GB201908430D0 (en) | 2019-07-24 |
| CN114245797A (en) | 2022-03-25 |
| AU2020291160A1 (en) | 2022-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279363A (en) | Pcsk9 antagonist compounds | |
| IL289252A (en) | Ep2 antagonist | |
| IL300211A (en) | Antagonist compounds | |
| EP4076492A4 (en) | Pcsk9 antagonist compounds | |
| GB201905721D0 (en) | Compounds | |
| GB201905552D0 (en) | Antagonists | |
| GB201910305D0 (en) | Compounds | |
| GB202019622D0 (en) | Antagonist compounds | |
| GB201908536D0 (en) | Compounds | |
| GB201908171D0 (en) | Compounds | |
| EP4317153A4 (en) | Abhd6 antagonist | |
| IL281448A (en) | Prodrugs of cgrp antagonists | |
| SG11202113348UA (en) | Cgrp antagonist compounds | |
| SG11202113345WA (en) | Cgrp antagonist compounds | |
| GB201910304D0 (en) | Compounds | |
| GB201908095D0 (en) | Carboxy-MIDA-boronate compounds | |
| GB201910865D0 (en) | Antagonist compounds | |
| GB201904158D0 (en) | Antagonist compounds | |
| GB202019922D0 (en) | Antagonist compounds | |
| GB201910526D0 (en) | Antagonist | |
| GB201812604D0 (en) | Antagonist compounds | |
| GB201909500D0 (en) | Antagonist | |
| GB202011892D0 (en) | Antagonist compounds | |
| GB202006823D0 (en) | Antagonist compounds | |
| GB202000906D0 (en) | Antagonist |